Intensive insulin treatment lowers mortality and morbidity in critical care. Our continuous blood glucose measurement eliminates the risks.
Intensive insulin treatment lowers mortality and morbidity in intensive care, but needs accurate monitoring of blood glucose levels which is today only possible by means of labor intensive ‘prick test’ or blood gas analyzers. Diramo offers continuous blood glucose measurement providing vital information on levels and trends and saving costs by intensive insulin therapy. The Flowsion team is set for approval in EU and US and commercializing Diramo